Demographic characteristics

 

MI patients
(n=221)

MACE
at 12 months
(n=31)

No MACE at 12 months
(n=190)

*P value

Age, year

Sex
Male, % (n)
Female, % (n)

Systolic BP, mmHg
Diastolic BP, mmHg
BMI, kg/m2
Creatinin, µmol/L
cTnI, ng/mL
CRP, mg/L
NT-proBNP, pg/ml
LVEF, %

Total CK, IU/L

STEMI, % (n)

NSTEMI, % (n)

MACE rate, % (n)

MACE details, % (n):

-Deaths
-Heart Failure related   hospitalisations
-Non fatal ACS
-Non fatal stroke

Comorbidities, % (n)

Hypertension
Diabetes
Dyslipidaemia
Smoker
Obesity
Known CAD
Stroke
Positive familial history
Atrial fibrillation

 

Auto-Antibodies

Anti-apoA-1 IgG, Index
Anti-HSP-60 antibodies, ng/ml

Anti-β2GPI IgG, GPL units
Anti-βGPI IgM, GPL units
Anti-βGPI IgA, GPL units

Anti-cardiolipin IgG, GPL units
Anti-cardiolipin IgM, GPL units
Anti-cardiolipin IgA, GPL units

Anti-β2GPI D4D5 IgA, GPL units

Anti-PC IgM, U/ml

64 (55–74)

 

78 (173)
22 (48)

120 (110-130)
70 (60-80)
25.8 (24–29)
84 (73–98)
0.50 (5–7)
6.0 (2.85-14)
785 (283-2057)
50 (45-55)

687 (273-1873)

54 (120)

 46 (101)

14 (31)

 

1 (3)
4 (9)

9 (19)
0 (0)

 

53 (117)
19 (43)
46 (102)
45 (99)
16 (35)
29 (65)
5 (12)
31 (69)
5 (11)

 

 

22.2 (15.9-31.3)
18.5 (11.5-37.1)

1.1 (0.9-1.3)
2.1 (1.3-3.5)
4.5 (3.5-6.1)

3.6 (2.4-5.4)
3.9 (2.5-5.7)
2.7 (1.9-4.1)

7.3 (4.9-10.4)

 

33.1 (22.5-55.2)

67 (55-80)

 

90 (28)
10 (3)

120 (100-130)
70 (60-80)
26.5 (24.5-29.5)
95 (77-114)
0.84 (0.10-3.42)
10.9 (3-31.4)
1503 (475-3500)
45 (35-50)

509 (264-1168)

43 (13)

58 (18)

-

 

-
-

-
-

 

51 (18)
32 (10)
42 (13)
23 (7)
23 (7)
52 (16)
13 (4)
29 (9)
13 (4)

 

 

31.4 (20.7-41.2)
22.5 (15.6-43)

1.1 (1.0-1.4)
2.4 (1.2-3.6)
4.8 (3.5-6.5)

4.4 (6.2-2.6)
4.0 (3.0-7.2)
3.2 (1.7-4.9)

7.8 (5.6-11.1)

 

37.9 (17-45.9)

63 (55-74)

76 (145)
24 (45)

120 (110-130)
70 (60-80)
25.8 (23.7-28.4)
83 (72-96)
0.38 (0.09-2.98)
5.9 (2.7-13)
771 (271-1641)
50 (45-60)

703 (280-1818)

56 (107)

44 (83)

 

-

-
-

-
-

 

52 (99)
17 (33)
47 (89)
5 (9)
15 (28)
26 (49)
4 (8)
32 (60)
4 (7)

 

 

20.6 (15.5-29.9)
17.8 (11.2-36.5)

1.0 (0.9-1.3)
2.1 (1.3-3.4)
4.5 (3.5-6.1)

3.5 (2.4-5.4)
3.9 (2.5-5.7)
2.7 (1.9-4.0)

7.2 (4.8-10.4)

 

32.8 (22.9-57.8)

0.43

 

0.10

 

0.52
0.93
0.18
0.01
0.36
0.11
0.07
0.0003

0.49

0.17

-

-

 

-
-

-
-

 

0.56
0.08
0.70
0.003
0.29
0.005
0.06
0.84
0.06

 

 

0.009
0.14

0.46
0.82
0.58

0.17
0.12
0.50

0.38

 

0.73

Table 1: All continuous variables are reported as median with interquartile range. *P-value was calculated according to Mann–Whitney U-test for continuous variable and according to exact bilateral Fischer test for proportions. P values were computed by comparing groups of patients with and without MACE during the follow-up.